Theoret Y - Search Results

1

Thiopurines in the management of Crohn disease: Safety and efficacy profile in patients with normal thiopurine S-methyl transferase activity - a retrospective study.

Benmassaoud A, Xie X, AlYafi M, Theoret Y, Bitton A, Afif W, Bessissow T. Benmassaoud A, et al. Among authors: theoret y. Can J Gastroenterol Hepatol. 2015 Oct 15:17199. Online ahead of print. Can J Gastroenterol Hepatol. 2015. PMID: 26469063 No abstract available.

2

Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity-A Retrospective Study.

Benmassaoud A, Xie X, AlYafi M, Theoret Y, Bitton A, Afif W, Bessissow T. Benmassaoud A, et al. Among authors: theoret y. Can J Gastroenterol Hepatol. 2016;2016:1034834. doi: 10.1155/2016/1034834. Epub 2016 Mar 29. Can J Gastroenterol Hepatol. 2016. PMID: 27446822 Free PMC article.

3

Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.

Balram B, Lubov J, Theoret Y, Afif W, Bitton A, Wild G, Lakatos PL, Bessissow T. Balram B, et al. Among authors: theoret y. Dig Dis Sci. 2021 May;66(5):1650-1657. doi: 10.1007/s10620-020-06427-8. Epub 2020 Jun 26. Dig Dis Sci. 2021. PMID: 32591969

4

Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease.

Kopylov U, Amre D, Theoret Y, Deslandres C, Seidman EG. Kopylov U, et al. Among authors: theoret y. J Pediatr Gastroenterol Nutr. 2014 Oct;59(4):511-5. doi: 10.1097/MPG.0000000000000455. J Pediatr Gastroenterol Nutr. 2014. PMID: 24918978

5

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Théorêt Y, Seidman EG. Dubinsky MC, et al. Among authors: theoret y. Gastroenterology. 2000 Apr;118(4):705-13. doi: 10.1016/s0016-5085(00)70140-5. Gastroenterology. 2000. PMID: 10734022 Clinical Trial.

6

Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy.

Cuffari C, Seidman EG, Latour S, Théorêt Y. Cuffari C, et al. Among authors: theoret y. Can J Physiol Pharmacol. 1996 May;74(5):580-5. Can J Physiol Pharmacol. 1996. PMID: 8884023

7

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.

Cuffari C, Théorêt Y, Latour S, Seidman G. Cuffari C, et al. Among authors: theoret y. Gut. 1996 Sep;39(3):401-6. doi: 10.1136/gut.39.3.401. Gut. 1996. PMID: 8949645 Free PMC article. Clinical Trial.

8

Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.

Le Sage S, David M, Dubois J, Powell J, McCuaig CC, Théorêt Y, Kleiber N. Le Sage S, et al. Among authors: theoret y. Pediatr Dermatol. 2018 Jul;35(4):472-477. doi: 10.1111/pde.13547. Epub 2018 May 23. Pediatr Dermatol. 2018. PMID: 29790593

9

Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD.

Moreau B, Clement P, Theoret Y, Seidman EG. Moreau B, et al. Among authors: theoret y. Therap Adv Gastroenterol. 2017 Nov;10(11):819-827. doi: 10.1177/1756283X17733657. Epub 2017 Oct 11. Therap Adv Gastroenterol. 2017. PMID: 29147133 Free PMC article.

10

Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency.

Autmizguine J, Krajinovic M, Rousseau J, Théorêt Y, Litalien C, Marquis C, Tapiéro B, Ovetchkine P. Autmizguine J, et al. Among authors: theoret y. Pharmacogenomics. 2012 Dec;13(16):1961-5. doi: 10.2217/pgs.12.175. Pharmacogenomics. 2012. PMID: 23215888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters